Breaking Down Axsome Therapeutics: 19 Analysts Share Their Views
Breaking Down Axsome Therapeutics: 19 Analysts Share Their Views
分解axsome therapeutics: 19位分析師分享他們的觀點
The standing of Axsome Therapeutics among financial experts becomes...In the preceding three months, 19 analysts have released ratings for Axsome Therapeutics (NASDAQ:AXSM), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，19位分析師公佈了Axsome Therapeutics（納斯達克股票代碼：AXSM）的評級，提出了從看漲到看跌的各種觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $128.05, a high estimate of $180.00, and a low estimate of $95.00. This current average has increased by 0.5% from the previous average price target of $127.41.
分析師分析的12個月目標股價提供了見解，平均目標價爲128.05美元，最高估計爲180.00美元，低估值爲95.00美元。目前的平均價格較之前的平均目標價127.41美元上漲了0.5％。
Investigating Analyst Ratings: An Elaborate Study
調查分析師評級：一項詳盡的研究
The standing of Axsome Therapeutics among financial experts becomes...
通過對分析師近期行...
登入免費觀看全文
登入/註冊